Results 191 to 200 of about 6,609,828 (279)
ABSTRACT Obstructive sleep apnea contributes to cardiovascular morbidity, and its treatment may mitigate this risk. Continuous positive airway pressure and mandibular advancement devices are established therapies, but their comparative cardiometabolic effects remain uncertain.
AlMothana Manasrah +11 more
wiley +1 more source
ABSTRACT Accurate peripheral blood oxygen saturation (SpO2) measurements are critical for evaluating sleep patients, particularly those with frequent desaturations due to pathological breathing events. We compared synchronised SpO2 measurements obtained from three anatomical sites (finger, forehead and toe) in patients undergoing routine Type 1 ...
Kellie R. Strickland +4 more
wiley +1 more source
ABSTRACT Exposure to reduced oxygen levels occurs in several real‐world contexts, such as during air travel or altitude exposure, and emerging evidence suggests that hypoxia may interact with molecular pathways involved in circadian regulation. This exploratory study investigated the effects of normobaric hypoxia on circadian phase shifting in humans ...
Renée Morin +6 more
wiley +1 more source
ABSTRACT Obstructive sleep apnoea (OSA) is common, but current diagnostic pathways rely on single‐night assessment and the apnoea–hypopnoea index. Both are limited for assessment of variability and linking only weakly to symptoms, comorbidity and treatment response.
Ludger Grote +29 more
wiley +1 more source
Ambulatory vs Office Blood Pressure Monitoring in Renal Transplant Recipients
Jafar Ahmed +3 more
semanticscholar +1 more source
Low Weight Loss Response to Incretin Analogs: A Systematic Review
ABSTRACT The development of GLP‐1 and GIP analogs has been a significant breakthrough in type 2 diabetes and obesity pharmacotherapy. However, individual responses to these medications can vary widely. This systematic review examines factors associated with low or no weight loss response to GLP‐1 and GIP analogs. Key predictors of poor response include
Pamela S. Gaskin, Peter S. Chami
wiley +1 more source
ABSTRACT Although there are conflicting clinical data on the efficacy of weight reduction in reducing secondary events in patients with comorbid overweight and obesity (OAO) and cardiovascular disease (CVD), there is excellent epidemiological and biological evidence of a cause–effect relationship between OAO, CVD, and other systemic complications ...
Wael Almahmeed +19 more
wiley +1 more source
F. Puisieux +5 more
semanticscholar +1 more source

